Five Prime Therapeutics (FPRX) PT Lowered to $9 at Roth Capital

February 28, 2020 7:21 AM EST Send to a Friend

Roth Capital analyst Tony Butler ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Five Prime Therapeutics (FPRX) PT Lowered to $9 at Roth Capital

Member Login

Free News Feed